1 Min Read
July 21 (Reuters) - Teligent Inc-
* Teligent Inc announces FDA approval of erythromycin topical gel usp, 2%
* Says we expect to launch the product in Q3 of 2017 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.